CVS Health (CVS) puts active on Amazon (AMZN) has agreed to acquire PillPack
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
CVS Health (CVS) PT Lowered to $84 at RBC Capital on Amazon Effect
June 29, 2018 7:10 AM EDTRBC Capital lowered its price target on CVS Health (NYSE: CVS) to $84.00 (from $91.00) while maintaining an Outperform rating to reflect Amazon's entrance into the pharmacy space.
"We acknowledge that Amazon has disrupted industries in the past, but believe that the stickiness of payer/ pharmacy... More
Buy CVS Health (CVS) and Express Scripts (ESRX) on Amazon/PillPack Deal Weakness - Mizuho
June 28, 2018 11:47 AM EDTMizuho analyst Ann Hynes said they would be buyers of CVS Health (NYSE: CVS) and Express Scripts (NASDAQ: ESRX) amid weakness related to Amazon's purchase of PillPack.
Hynes said the bark of the deal is likely worse than the bite, at lease initially. "Obviously from a multiple perspective, this announcement will weigh on valuation. From an earnings and cash flow perspective, that impact is less clear and our initial thoughts is market share gains will be limited, at least in the intermediate-term. We confirmed... More
